Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease

Clinics

Volumn 68, Issue 6, 2013, Pages 772-776

  Caram, Laura Miranda de Oliveira ^a   Ferrari, Renata ^a   Naves, Cristiane Roberta ^a   Tanni, Suzana Erico ^a   Coelho, Liana Sousa ^a   Zanati, Silméia Garcia ^a   Minicucci, Marcos Ferreira ^a   Godoy, Irma ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Chronic obstructive pulmonary disease; Echocardiography; Electrocardiography; GOLD; Spirometry

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; REFERENCE VALUE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME;

AGED; C-REACTIVE PROTEIN; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84879302996     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(06)08     Document Type: Article

References (31)

1. GOLD. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary update 2011. www.goldcopd.org.
2. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connet JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233-9.
3. Sin DD, Wu LL, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127(6):1952-9.
4. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007;12(5):634-41, http://dx.doi.org/10.1111/j.1440-1843.2007.01136.x.
5. WHO. World Health Organization in www.who.int/cardiovascular_disease/en/acessadoemjulhode2012.
6. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, et al. Cigarette smoking and progression of atherosclerosis: The atherosclerosis risk in communities (ARIC) study. JAMA. 1998;279(2):119-24, http://dx.doi.org/10.1001/jama.279.2.119.
7. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potencially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52, http://dx.doi.org/10.1016/S0140-6736(04)17018-9.
8. Sin DD, Man SF. Impact of cancers and cardiovascular disease in chronic obstructive pulmonary disease.Obstructive, occupational and environmental diseases. Curr Opin Pulm Med. 2008;14(2):115-21, http://dx.doi.org/10.1097/MCP.0b013e3282f45ffb.
9. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514-9.
10. Fisher LD, Belle GV. Biostatistics: a methodology for health science. New York: John Wiley; 1993.
11. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962-9, http://dx.doi.org/10.1183/09031936.00012408.
12. Fabbri LM, Luppi F, Beghe B, Rabe KF. Update in chronic obstructive pulmonary disease 2005. Am J Respir Crit Care Med. 2006;173(10):1056-65, http://dx.doi.org/10.1164/rccm.2603005.
13. American Thoracic Society Statement. Standardization of spirometry- 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136(5):1285-98.
14. Pereira CAC, Barreto SP, Simoes JG, Pereira FWL, Gerstler JG, Nakatani J. Valores de referência para a espirometria em uma amostra da população brasileira adulta. J Bras Pneumol. 1992;18(1):10-22.
15. Celli BR, Cote CG, Marin JM, Casanova C. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-12.
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52, http://dx.doi.org/10.1161/01.HYP.0000107251.49515.c2.
17. Mivris DM, Goldberger AL. Electrocardiography. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's Heart Disease. A test book of cardiovascular medicine. Philadelphia, PA, USA: Saunders Elsevier. 2008;149-93.
18. Lang RM Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Ecocardiogr. 2006;7(2):79-108.
19. Schena M, Clini E, Errera D, Quadri A. Echo-Doppler evaluation of left ventricular impairment in chronic corpulmonale. Chest. 1996;109(6):1446-51, http://dx.doi.org/10.1378/chest.109.6.1446.
20. Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M, et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med. 2000;162(2 Pt1):670-5.
21. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26(18):1887-94, http://dx.doi.org/10.1093/eurheartj/ehi291.
22. Funk CG, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest. 2008;133(6):1354-9, http://dx.doi.org/10.1378/chest.07-2685.
23. Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, Ionescu AA, et al. Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med. 2010;104(8):1171-8, http://dx.doi.org/10.1016/j.rmed.2010.01.020.
24. Gupta NK, Agrawal RK, Srivastav AB, Ved ML, Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease. Lung India. 2011;28(2):105-9.
25. Freixa X, Portillo K, Paré C, Garcia-Aymerich J, Gomez FP, Benet M, et al. Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J. 2012; Sep 27 [Epub ahead of print].
26. Kazik A, Wilczek K, Polonski L. Management of diastolic heart failure. Cardiol J. 2010;17(7):558-65.
27. Thurnheer R, Muntwyler J, Stammberger U, Bloch KE, Zollinger A, Weder W, et al. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest. 1997;112(1):122-8, http://dx.doi.org/10.1378/chest.112.1.122.
28. Brekke PH, Omland T, Smith P, Soyseth V. Underdiagnosis of myocardial infarction in COPD - Cardiac infarction injury score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med. 2008;102(9):1243-7, http://dx.doi.org/10.1016/j.rmed.2008.04.010.
29. Fontes-Carvalho R, Leite Moreira A. Heart failure with preserved ejection fraction: fighting misconceptions for a new approach. Arq Bras Cardiol. 2011;96(6):504-14, http://dx.doi.org/10.1590/S0066-782X20110.00600012.
30. Abusaid GH, Barbagelata A, Tuero E, Mahmood A, Sharma G. Diastolic dysfunction and COPD exacerbation. Postgrad Med. 2009;121(4):76-81, http://dx.doi.org/10.3810/pgm.2009.07.2033.
31. Minai AO, Chaouat A, Adnot S. Pulmonary Hypertension in COPD: Epidemiology, Significance, and Management: Pulmonary Vascular Disease: The Global Perspective. Chest. 2010;137(6 Suppl):39S-51S, http://dx.doi.org/10.1378/chest.10-0087.